lion-20260317
0002052959false00020529592026-03-172026-03-170002052959dei:OtherAddressMember2026-03-172026-03-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 17, 2026
Lionsgate Studios Corp.
(Exact name of registrant as specified in charter)
British Columbia, Canada
(State or Other Jurisdiction of Incorporation)
001-42635N/A
(Commission File Number)(IRS Employer Identification No.)
(Address of principal executive offices)
250 Howe Street, 20th Floor
Vancouver, British Columbia V6C 3R8
and
2700 Colorado Avenue
Santa Monica, California 90404
Registrant’s telephone number, including area code: (877848-3866
No Change
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Shares, no par value per shareLIONNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 5.07 Submission of Matters to a Vote of Security Holders.

On March 17, 2026, Lionsgate Studios Corp. (the “Company”) held its Annual General and Special Meeting of Shareholders (the “Annual Meeting”) to consider and vote upon the election of each of the nominated directors to the Company’s Board of Directors (the “Board”), the reappointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026, and an advisory vote to approve executive compensation. The proposals are described in detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on February 3, 2026.

At the Annual Meeting, 90.92% of the Company’s Common Shares (the “Common Shares”) entitled to vote at the Annual Meeting were represented in person or by proxy. Based on the results of the vote, shareholders voted to elect all of the Company's director nominees, approved the re-appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026, and approved the advisory vote on executive compensation.

The number of votes cast for or withheld from the election of each director and the reappointment of Ernst & Young LLP, and the number of votes cast for, against or abstaining from the advisory vote to approve executive compensation are set forth below. The voting results disclosed below are final and have been certified by Broadridge Financial Solutions, the scrutineer and independent Inspector of Elections.

Election of Directors
Number of Shares
Voted For
Number of Shares
Withheld
Percentage of Shares Voted “For” of Shares Voted
Gordon Crawford
205,656,717
20,693,744
90.86%
Jon Feltheimer
212,098,474
14,251,987
93.70%
Emily Fine
195,339,739
31,010,722
86.30%
Michael T. Fries
180,809,528
45,540,933
79.88%
John D. Harkey, Jr.
205,442,205
20,908,256
90.76%
Susan McCaw
205,550,947
20,799,514
90.81%
Steven Mnuchin
225,846,556
503,905
99.78%
Yvette Ostolaza
203,942,675
22,407,786
90.10%
Mark H. Rachesky, M.D.
192,087,630
34,262,831
84.86%
Richard Rosenblatt
203,972,267
22,378,194
90.11%
Harry E. Sloan
200,497,754
25,852,707
88.58%
Number of
Shares
Voted For
Number of
Shares
Voted Withheld
Percentage of Shares Voted
“For” of Shares Voted
Re-Appointment of Ernst & Young LLP
262,890,005
971,214
99.63%
Number of Shares
Voted For
Number of Shares
Voted Against
Number of Shares
Abstained
Percentage of Shares Voted “For” of Shares Voted
Advisory Vote to Approve Executive Compensation
181,517,544
43,857,685
975,232
80.19%














Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No.Description
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 18, 2026Lionsgate Studios Corp.
/s/ James W. Barge
James W. Barge
Chief Financial Officer